-
Mashup Score: 0Mobile App - ADA Meeting News - 9 day(s) ago
MOBILE APP Developed specifically for the ADA’s 85th Scientific Sessions, the coordinating mobile event app and Online Planner are your go-to meeting resources with details on educational session information, news […]
Source: www.adameetingnews.orgCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 0Continuous Glucose Monitoring in Hospitalized Patients With Type 2 Diabetes: A Step Forward in Inpatient Glycemic Control - 9 day(s) ago
To determine the effect and safety of continuous glucose monitoring (CGM) use in glycemic control compared to standard approach in hospitalized patients with type 2 diabetes.
Source: www.endocrinepractice.orgCategories: General Medicine News, EndocrinologyTweet-
This study demonstrates that Freestyle Libre 2 and 3 significantly improves glycemic control in hospitalized patients with type 2 diabetes: https://t.co/bKQXpmLhRb #endocrinology #diabetes @Els_ENDO @vtangpricha
-
-
Mashup Score: 4Scientists Training Course 2025 - 9 day(s) ago
EASD will hold its 31st Scientists Training Course in Barcelona, Catalonia, Spain from 10 -14 November 2025, with the objective of promoting new talents in the field of diabetes research and fostering diabetes research in centres throughout the world. The course is supported by Lilly Diabetes. Content/Programme The course programme, organized by Joan Marc Servitja, PhD and Rosa Gasa, PhD, offers a comprehensive overview of current research in diabetes, integrating daily lectures with hands-on training in
Source: www.easd.orgCategories: General Medicine News, EndocrinologyTweet-
Applications for the 31st EASD Scientists Training Course 2025 are open! Join us for a unique opportunity to advance your career in diabetes research. Open to early-career researchers 🌍. Apply via MyEASD | Learn more 👉 https://t.co/HwPg1rkN8s Supported by @LillyDiabetesIn https://t.co/dqWetlBFxp
-
-
Mashup Score: 10
CHICAGO — A once-weekly basal insulin conferred similar HbA1c to once-daily insulins among adults with type 2 diabetes, both in previous basal insulin users and first-time insulin users, according to data from the QWINT trials. At the American Diabetes Association Scientific Sessions, researchers presented findings from the QWINT-1, QWINT-3 and QWINT-4 trials, which assessed once-weekly
Source: www.healio.comCategories: General Medicine News, EndocrinologyTweet-
🚨Presented today at #ADA2025: Data from three QWINT trials showed once-weekly insulin efsitora provided similar HbA1c reductions as once-daily basal insulins in adults with type 2 #diabetes. @athenatsimikas @ADA_DiabetesPro #ADASciSessions @GoHealio https://t.co/pvL1EOoAly
-
-
Mashup Score: 1Swapping diet drinks for water linked to greater weight loss, diabetes remission in women - 10 day(s) ago
CHICAGO — Women who replaced their lunchtime diet beverage with water had greater weight loss and achieved diabetes remission compared with women who continued drinking diet beverages, according to new research. Hamid R. Farshchi, MD, PhD, CEO of D2Type and former associate professor at the University of Nottingham School of Life Sciences, U.K., presented a randomized study at the
Source: www.healio.comCategories: General Medicine News, EndocrinologyTweet-
💧Drinking water could be beneficial for your health. Data presented at #ADA2025 showed women who switched from a diet beverage to water lost more weight and were more likely to achieve #diabetes remission. @UoNLifeSci @ADA_DiabetesPro @GoHealio https://t.co/EYD1CMmt5p
-
-
Mashup Score: 3Oral Semaglutide Significantly Improves Cardiovascular Outcomes in Individuals with Type 2 Diabetes | American Diabetes Association - 10 day(s) ago
A recent study found that oral semaglutide offers meaningful cardiovascular benefits for people with type 2 diabetes, lowering risk by 14%.
Source: diabetes.orgCategories: General Medicine News, EndocrinologyTweet-
PRESS RELEASE: Oral Semaglutide Significantly Improves Cardiovascular Outcomes in Individuals with Type 2 Diabetes Details: https://t.co/KuLIuYsJEh #ADASciSessions https://t.co/QTsuXL8J4m
-
-
Mashup Score: 2Intervention eliminates population weight gain, prompts patients to seek care for weight - 10 day(s) ago
CHICAGO — An intervention designed to emphasize management of overweight and obesity in primary care settings was associated with population-wide weight loss, researchers reported at the American Diabetes Association Scientific Sessions. The PATHWEIGH intervention was implemented across Colorado at institutions whose primary care practices bought into the process, Leigh Perreault, MD,
Source: www.healio.comCategories: General Medicine News, EndocrinologyTweet-
🏥 An intervention centered on #obesity management in primary care clinics led to a greater reduction in body weight than usual care. Dr. Leigh Perreault of @CUAnschutz shares some insights at #ADA2025. @ADA_DiabetesPro https://t.co/38t3zPl25M
-
-
Mashup Score: 3Inhaled insulin safe, effective for children with diabetes - 10 day(s) ago
CHICAGO — Inhaled insulin is an “important alternative” to injected rapid-acting analog insulin for children and teens with diabetes, according to a speaker at the American Diabetes Association Scientific Sessions. Healio previously reported data from the INHALE-3 trial that demonstrated technosphere insulin (Afrezza, MannKind Pharma), a rapid-acting human insulin
Source: www.healio.comCategories: General Medicine News, EndocrinologyTweet-
💡Could inhaled #insulin be a therapeutic option for children with #diabetes? Data from INHALE-1 presented at #ADA2025 today showed technosphere insulin conferred similar HbA1c reductions as a rapid-acting analog in kids and teens. @HallerMichael https://t.co/wvl3fSUH50
-
-
Mashup Score: 0Dr. Felicia Hill-Briggs Health Equity Trailblazers in Diabetes Award debuts - ADA Meeting News - 10 day(s) ago
A leading scholar in epidemiology and health equity, Tiffany L. Gary-Webb, PhD, MHS, will receive the inaugural Dr. Felicia Hill-Briggs Health Equity Trailblazers in Diabetes Award.
Source: www.adameetingnews.orgCategories: General Medicine News, EndocrinologyTweet-
Sunday at #ADASciSessions: @DrTGaryWebb will receive the inaugural Dr. Felicia Hill-Briggs Health Equity Trailblazers in Diabetes Award. 🏆 🔗 Learn more: https://t.co/Luhz0bAFAw https://t.co/qivXwEYSOT
-
-
Mashup Score: 1Symposium will explore next gen agents for type 2 diabetes and obesity - ADA Meeting News - 10 day(s) ago
Panelists, including Dimitris Papamargaritis, MCRP, PhD, will discuss emerging therapies targeting the hormones glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), glucagon, and amylin.
Source: www.adameetingnews.orgCategories: General Medicine News, EndocrinologyTweet-
What does the treatment landscape look like for type 2 diabetes and obesity? An #ADASciSessions symposium will spotlight emerging hormone-targeting therapies. 🔗 Preview the session here: https://t.co/4hBstjvAXM https://t.co/aclrz9YZ7D
-
📱 tomorrow is the big day! Start your day right! Download the ADA app for all session schedules and updates. #ADASciSessions https://t.co/EzIDiSWK3C https://t.co/6KsgrAro6x